In The News Posted November 22, 2020 Share Posted November 22, 2020 TARRYTOWN, N.Y., Nov. 21, 2020 /PRNewswire/ -- First treatment of any kind to have prospectively confirmed and statistically significant anti-viral activity against SARS-CoV-2 Authorized for recently diagnosed, mild to moderate COVID-19 in high-risk patients Initial doses of REGEN-COV2...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.